Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ENVI's concession for clinical investigations of short-term high-risk devices

This article was originally published in Clinica

Executive Summary

When the European Parliament’s lead committee voted on the compromise amendments to the European Commission’s proposed medical devices Regulation on 25 September, there were few changes to the articles that most concern industry when compared with the same articles in the 13 September proposed compromise amendments that had been put forward by ENVI rapporteur Dagmar Roth Behrendt.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT100921

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel